Lin Zheng

Dr. Lin Zheng


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
LMLi-Cai Mo
Li-Cai Mo
XZXian-Jun Zhang
Xian-Jun Zhang
HZHai-Hong Zheng
Hai-Hong Zheng
XHXiao-Peng Huang
Xiao-Peng Huang
LZLin Zheng
Lin Zheng
LZLin Zheng
Lin Zheng
Introduction: On prostate biopsy, multiparametric magnetic resonance imaging (mpMRI) and the Prostate Health Index (PHI) have allowed prediction of clinically significant prostate cancer (csPCa).Methods: To predict the likelihood of csPCa, we created a nomogram based on a multivariate model that included PHI and mpMRI. We assessed 315 males who were scheduled for prostate biopsies.Results: We used the Prostate Imaging Reporting and Data System version 2 (PI-RADS V2) to assess mpMRI and optimize PHI testing prior to biopsy. Univariate analysis showed that csPCa may be identified by PHI with a cut-off value of 77.77, PHID with 2.36, and PI-RADS with 3 as the best threshold. Multivariable logistic models for predicting csPCa were developed using PI-RADS, free PSA (fPSA), PHI, and prostate volume. A multivariate model that included PI-RADS, fPSA, PHI, and prostate volume had the best accuracy (AUC: 0.882). Decision curve analysis (DCA), which was carried out to verify the nomogram’s clinical applicability, showed an ideal advantage (13.35% higher than the model that include PI-RADS only).Discussion: In conclusion, the nomogram based on PHI and mpMRI is a valuable tool for predicting csPCa while avoiding unnecessary biopsy as much as possible.

30 May 2025 in Medicine
Verified
Journal Article
Open access
FXFeng Xuan
Feng Xuan
TLTian Lv
Tian Lv
LZLin Zheng
Lin Zheng
SYShengjian Mm Yu
Shengjian Mm Yu
MDMengjuan Mb Ding
Mengjuan Mb Ding
Epidemiological studies have demonstrated that inflammatory cytokines are associated with cancer development. However, the causal relationship between inflammatory cytokines and glioblastoma remains unclear. We used a two-sample Mendelian randomization approach to determine the potential causal effects of inflammatory cytokines on glioblastoma. Genome-wide association study summary statistics for 41 inflammatory cytokines were obtained from the University of Bristol database, and 91 inflammatory cytokines were acquired from the genome-wide association study catalog database. Genetic data on glioblastoma were downloaded from the FinnGen consortium (R10). Mendelian randomization analysis and Bayesian weighted Mendelian randomization analysis were performed to investigate the causal relationship between inflammatory cytokines and glioblastoma risk. A combination of Mendelian randomization (MR)-Egger, MR-Pleiotropy Residual Sum and Outliers, and Radial MR methods was employed to assess horizontal pleiotropy, which is a potential bias in MR studies. The Cochran Q test was used to quantify the degree of heterogeneity. Finally, we conducted a comprehensive meta-analysis to confirm the robustness of our findings. Increased levels of tumor necrosis factor β (odds ratio [OR] = 1.597, 95% CI: 1.143–2.230, P = .006) and interleukin-10 (OR = 1.452, 95% CI: 1.059–1.992, P = .021) were associated with an increased risk of glioblastoma. Conversely, higher levels of circulating fibroblast growth factor 21 (OR = 0.456, 95% CI: 0.276–0.754, P = .002) and macrophage inflammatory protein 1a (OR = 0.743, 95% CI: 0.558–0.990, P = .042) were associated with a decreased risk of glioblastoma. No significant causal effect on inflammatory cytokines from glioblastoma was detected, and no significant heterogeneity in instrumental variables or horizontal pleiotropy was observed. Our findings indicate that specific inflammatory cytokines may play a role in glioblastoma development, acting as either protective factors or risk factors. This offers valuable insights into the disease mechanism and suggests that targeting these cytokines could be a potential strategy for glioblastoma prevention and treatment.

20 October 2026 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
RYRuxuan Yan
Ruxuan Yan
EWEnyu Wang
Enyu Wang
LZLingying Zhu
Lingying Zhu
LJLuxi Jin
Luxi Jin
ZZZhirui Zhou
Zhirui Zhou
LZLin Zheng
Lin Zheng
Routine abdominal CT contains quantitative muscle and skeletal information. We evaluated associations of automatically extracted CT body composition marker